Cover - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Mar. 18, 2026 |
Jun. 30, 2025 |
|
| Document Type | 10-K | ||
| Amendment Flag | false | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Document Period End Date | Dec. 31, 2025 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2025 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity File Number | 001-39669 | ||
| Entity Registrant Name | Coeptis Therapeutics Holdings, Inc. | ||
| Entity Central Index Key | 0001759186 | ||
| Entity Tax Identification Number | 98-1465952 | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Address, Address Line One | 105 Bradford Rd | ||
| Entity Address, Address Line Two | Suite 420 | ||
| Entity Address, City or Town | Wexford | ||
| Entity Address, State or Province | PA | ||
| Entity Address, Postal Zip Code | 15090 | ||
| City Area Code | 724 | ||
| Local Phone Number | 934-6467 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | true | ||
| Elected Not To Use the Extended Transition Period | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 28,225,766 | ||
| Entity Common Stock, Shares Outstanding | 6,223,221 | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Award Timing MNPI Disclosure [Text Block] | We do not grant equity awards in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our common stock, and do not time the public release of such information based on award grant dates. During the last completed fiscal year, we have not made awards to any named executive officer or director during the period beginning four business days before and ending one business day after the filing of a period report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on Form 8-K, and we have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. | ||
| Award Timing MNPI Considered [Flag] | true | ||
| Auditor Firm ID | 6920 | ||
| Auditor Name | Astra Audit and Advisory LLC | ||
| Auditor Location | Tampa, Florida | ||
| Common Stock, par value $0.0001 per share | |||
| Title of 12(b) Security | Common Stock, par value $0.0001 per share | ||
| Trading Symbol | COEP | ||
| Security Exchange Name | NASDAQ | ||
| Warrants, each whole warrant exercisable for one-half of one share of Common Stock for $230.00 per whole share | |||
| Title of 12(b) Security | Warrants, each whole warrant exercisable for one-half of one share of Common Stock for $230.00 per whole share | ||
| Trading Symbol | COEPW | ||
| Security Exchange Name | NASDAQ |